All In Biotech

Drug Trial Radar · NCT00827788

Comparison Between Iso-Osmolar and Ipo-Osmolar Contrast Agents in Patients With Acute Myocardial Infarction (AMI) Undergoing Primary Percutaneous Coronary Intervention (PCI)

The Contrast Media and Nephrotoxicity Following Coronary Revascularization by Primary Angioplasty for Acute Myocardial Infarction. The CONTRAST-AMI Study.

Last checked: Nov 19, 2026Latest source record: Nov 16, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 432 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

432

Planned (sponsor's estimate)

Start

Dec 2008

Primary completion

Apr 2010

Sponsor

Lead sponsor
Ospedale San DonatoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Ospedale Le Scotte; Ospedale della Misericordia - Grosseto
First posted
Jan 23, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Prevention
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the incidence of contrast induced nephropathy and myocardial tissue reperfusion following iso-osmolar iodixanol or ipo-osmolar iopromide administration in patients with acute myocardial infarction undergoing primary PCI.

Conditions

  • Contrast Induced Nephropathy
  • Acute Myocardial Infarction

Interventions

  • IodixanolDrug

    Iso-osmolar contrast medium (Iodixanol) will be administered during PCI

  • IopromideDrug

    Low-osmolar contrast medium (Iopromide) will be administered during PCI

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Contrast Induced Nephropathy (CIN) between the two study groups, defined as relative increase of serum Creatinine of 25% or more from basal valuesTime frame: days 1, 2, 3, and at discharge

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cardiovascular Department, Ospedale S.Donato

    Arezzo, AR, Italy

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.